Showing results (121-130 of 433) with videos related to
Sort By:
Pageof 44
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.Revista Espanola De Cardiologia|January 5, 2002
[Chest pain units: state of the art of the management of patients with chest pain in the emergency department]R Bassan, W B GiblerLeukemia|July 13, 2007
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burdenA M Vannucchi, E Antonioli, P Guglielmelli, et al.Stem Cells (Dayton, Ohio)|July 1, 1994
Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemiaA Biondi, A RambaldiThe Cochrane Database of Systematic Reviews|November 1, 2001
S-adenosyl-L-methionine for alcoholic liver diseasesA Rambaldi, C GluudLiver|March 21, 2002
Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group ReviewA Rambaldi, C GluudLiver|April 25, 2001
Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosisA Rambaldi, C GluudThe Cochrane Database of Systematic Reviews|April 21, 2006
S-adenosyl-L-methionine for alcoholic liver diseasesA Rambaldi, C GluudThe Cochrane Database of Systematic Reviews|April 23, 2005
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosisA Rambaldi, C GluudThe Cochrane Database of Systematic Reviews|October 20, 2005
Propylthiouracil for alcoholic liver diseaseA Rambaldi, C GluudPageof 44